Clinical Study Results Prove Versagel® and Versastique™ Provide A More Effective Delivery System for Natural Anti-Aging Benefits in Personal Care and Cosmetics
Penreco sponsored an Independent, 4-week, randomized, double blinded study conducted by a clinical research lab
Indianapolis, IN – December 16, 2019- Impressive results from a recent clinical trial show the superiority of the anti-aging benefits of Calumet’s Versagel® SQ & Versastique™ SQ compared to squalane (SQ)and a placebo. The tactile, visual, image, and self-assessment analysis showed improved efficacy in 6 anti-aging categories: Periocular Wrinkles, Skin Smoothness & Texture, Overall Appearance, Skin Tone Evenness, Skin Elasticity, and Skin Radiance. The study not only showed the visual and tactile skin benefits, but also the rapid rate of anti-aging improvement experienced by participants in just two to four weeks.
“It was important to conduct this study to prove the superior anti-aging efficacy provided by our proprietary gelling technology in cosmetics and personal care,” said Mark Voelker, Penreco Technology Manager. “Over the years, we’ve shown that our Versagel® line provides a better way to formulate by conducting clinical trials with various gelled substrates, but this is the first time we’ve done so with Squalane and with Versastique™”
There are numerous products on the market with anti-aging claims, but not all the claims are clinically proven. This trial provides Penreco® suppliers, customers, and consumers with the data and knowledge to formulate high-performing anti-aging products using Versagel® or Versastique™ ingredients.
I am especially excited about the results of the Versastique SQ product
– Ryan Cameron, PhD
“I am especially excited about the results of the Versastique SQ product,” remarked Dr. Ryan Cameron, Penreco Senior Chemist & Technology Specialist. “This is a newly patented product we launched this year. We saw amazing results with Versagel SQ (gel) and with Versastique™ SQ, which is a solid stick, with how well it performed regarding skin radiance, skin smoothness & texture, and skin tone evenness.”
The unique system for thickening and gelling hydrocarbon materials found in Penreco® products provides customers a better way to formulate. With an infinite number of customized rheological properties available, the Versagel® and Versastique™ products are clear, colorless, hydrophobic, thermally reversible and without syneresis. Versastique™ also provides a simplified creation of functional and aesthetic solid stick applications. The unique chemical properties of Penreco® proprietary products bring out the best characteristics of a substrate and amplify the efficacy in formulated applications.
The Penreco® proprietary method of gelling squalane, a natural ingredient derived from sugar, provides customers a better way to create high-performance anti-aging products. Squalane is the biomimetic form of Squalene which is naturally present in the skin lipid barrier. Squalane is renowned for its exceptional skin compatibility and deep moisturizing benefits. It closely mimics the body’s natural moisturizers and is absorbed quickly and effectively, without leaving greasy reside on the skin.
Full results of the study will be shared at a special event on Tuesday, December 17, 2019 at the Society of Cosmetic Chemists 73rd Annual Scientific Meeting & Technology Showcase.
The Versagel® and Versastique™ independent clinical study was performed by Thomas J. Stephens & Associates, Inc. during the second quarter of 2019.
Penreco® is a registered trademark of Calumet Refining, LLC, which is a wholly-owned subsidiary of Calumet Specialty Products Partners, L.P. The Penreco® products are leading high-quality specialty Gelled Hydrocarbons (Versagel®, Versastique™ and Synergel® products) and unique lines of Petrolatums, Waxes, and White Mineral Oils for use in cosmetics, personal care, and pharmaceutical applications.
About Calumet Specialty Products Partners, L.P.
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is a master limited partnership and a leading independent producer of high-quality, specialty hydrocarbon products in North America. Calumet processes crude oil and other feedstocks into customized lubricating oils, solvents and waxes used in consumer, industrial and automotive products; produces fuel products including gasoline, diesel and jet fuel. Calumet is headquartered in Indianapolis, Indiana and operates 11 manufacturing facilities located in Louisiana, Missouri, Montana, New Jersey, Pennsylvania, and Texas.